Organoidsciences Ltd. Stock: price and insider trades · South Korea
오가노이드사이언스
No insider purchase over the last 90 days. The latest, by 유종만, was filed 06 Apr 2026.
Organoidsciences Ltd.: what insiders have been doing
Organoidsciences Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). 1 insider has disclosed 1 filing since 2 November 2025.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The most recent open-market purchase was published on 6 April 2026, 218 days ago.
With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 2,655 companies we follow on the same exchange. Our records for Organoidsciences Ltd. go back to 2025, with 1 purchase and 1 sale on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -59.1%Entry ₩20,700 · Close at T+90 ₩8,475
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Organoidsciences Ltd.
Organoid Science is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies related to organoids.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
